CLINICAL_TRIALS
safety_alert
· 2013-09-30
Clinical Trial Update: Kidney Damage in Patients With Normal eGFR [Phase 4]
Summary
Phase 4 clinical trial update from Bracco Diagnostics reports kidney damage observed in patients with normal eGFR; results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Bracco Diagnostics, Inc | Conditions: Coronary Artery Stenosis | Phase 4 | Status: COMPLETED | Results posted: 2013-09-30